Skip to main content
Top
Published in: Clinical Autonomic Research 2/2024

25-04-2024 | Parkinson's Disease | Letter to the Editor

A case report illustrating the ‘hypotensive twilight zone’ in Parkinson’s disease; an under-recognised presentation of orthostatic hypotension

Authors: J. Gert van Dijk, Bastiaan R. Bloem

Published in: Clinical Autonomic Research | Issue 2/2024

Login to get access

Excerpt

A 67-year-old woman with Parkinson’s disease (PD) was referred for almost daily episodes of reduced responsiveness. Most spells occurred during breakfast, 30 min after taking her first levodopa dose. Her husband noticed she slumped backwards in her chair, staying upright. She stared ahead and did not respond when prodded or spoken to. Such spells could last one hour. She would later remember parts of such periods. Spells also occurred when sitting on a stool while showering. When helped to lie down, the spells ended immediately. She had PD since the age of 60 and used a combination of levodopa/carbidopa and levodopa/benserazide with a net daily dose of 750 mg of levodopa. Her prior history included knee joint problems. Cognitive problems were absent then and later. …
Literature
1.
go back to reference Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG, ESC Scientific Document Group (2018) 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 39(21):1883–1948. https://doi.org/10.1093/eurheartj/ehy037CrossRefPubMed Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG, ESC Scientific Document Group (2018) 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 39(21):1883–1948. https://​doi.​org/​10.​1093/​eurheartj/​ehy037CrossRefPubMed
2.
go back to reference Van Dijk JG, Thijs RD, van Zwet E, Tannemaat MR, van Niekerk J, Benditt DG, Wieling W (2014) The semiology of tilt-induced reflex syncope in relation to electroencephalographic changes. Brain 137:576–585CrossRefPubMed Van Dijk JG, Thijs RD, van Zwet E, Tannemaat MR, van Niekerk J, Benditt DG, Wieling W (2014) The semiology of tilt-induced reflex syncope in relation to electroencephalographic changes. Brain 137:576–585CrossRefPubMed
4.
go back to reference van Dijk JG (2020) The meaning of ‘consciousness’ in syncope and related disorders. In: Brignole M, Benditt DG (eds) Syncope: an evidence-based approach, 2nd edn. Springer, Cham, pp 17–32CrossRef van Dijk JG (2020) The meaning of ‘consciousness’ in syncope and related disorders. In: Brignole M, Benditt DG (eds) Syncope: an evidence-based approach, 2nd edn. Springer, Cham, pp 17–32CrossRef
6.
go back to reference Karp HR, Weissler AM, Heyman A (1961) Vasodepressor syncope: EEG and circulatory changes. Arch Neurol 5:94–101CrossRefPubMed Karp HR, Weissler AM, Heyman A (1961) Vasodepressor syncope: EEG and circulatory changes. Arch Neurol 5:94–101CrossRefPubMed
7.
go back to reference Luft UC, Noell WK (1956) Manifestations of brief instantaneous anoxia in man. J Appl Physiol 8:444–454CrossRefPubMed Luft UC, Noell WK (1956) Manifestations of brief instantaneous anoxia in man. J Appl Physiol 8:444–454CrossRefPubMed
Metadata
Title
A case report illustrating the ‘hypotensive twilight zone’ in Parkinson’s disease; an under-recognised presentation of orthostatic hypotension
Authors
J. Gert van Dijk
Bastiaan R. Bloem
Publication date
25-04-2024
Publisher
Springer Berlin Heidelberg
Published in
Clinical Autonomic Research / Issue 2/2024
Print ISSN: 0959-9851
Electronic ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-024-01032-5

Other articles of this Issue 2/2024

Clinical Autonomic Research 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine